Skip to main content
Erschienen in: Current Cardiovascular Imaging Reports 4/2011

01.08.2011 | Clinical Trial Report

Test the Heart Nerves: True Grit for Prognosis?

verfasst von: Marcus V. Simões, J. Antonio Marin-Neto

Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Excerpt

Jacobson AF, Senior R, Cerqueira MD, et al.; on behalf of the ADMIRE-HF Investigators: Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010, 55:2212–2221. …
Literatur
1.
Zurück zum Zitat Kline RC, Swanson DP, Wieland DM, et al. Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med. 1981;22:129–32.PubMed Kline RC, Swanson DP, Wieland DM, et al. Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med. 1981;22:129–32.PubMed
2.
Zurück zum Zitat Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819–23.PubMedCrossRef Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819–23.PubMedCrossRef
3.
Zurück zum Zitat Merlet P, Valette H, Dubois-Randle JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471–7.PubMed Merlet P, Valette H, Dubois-Randle JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471–7.PubMed
4.
Zurück zum Zitat Verberne HJ, Brewster LM, Somsen GA, Van Eck-Smit BLF. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J. 2008;29:1147–59.PubMedCrossRef Verberne HJ, Brewster LM, Somsen GA, Van Eck-Smit BLF. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J. 2008;29:1147–59.PubMedCrossRef
5.
Zurück zum Zitat Agostini D, Verberne HJ, Burchert W, et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging. 2008;35:535–46.PubMedCrossRef Agostini D, Verberne HJ, Burchert W, et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging. 2008;35:535–46.PubMedCrossRef
6.
Zurück zum Zitat Simões MV, Barthel P, Matsunari I, Nekolla SG, Schömig A, Schwaiger M, et al. Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction. Eur Heart J. 2004;25(7):551–7.PubMedCrossRef Simões MV, Barthel P, Matsunari I, Nekolla SG, Schömig A, Schwaiger M, et al. Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction. Eur Heart J. 2004;25(7):551–7.PubMedCrossRef
7.
Zurück zum Zitat Bax JJ, Kraft O, Buxon AE, et al. 123I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac alectrophysiology testing: a prospective multicenter pilot study. Circ Cadiovasc Imaging. 2008;1:131–40.CrossRef Bax JJ, Kraft O, Buxon AE, et al. 123I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac alectrophysiology testing: a prospective multicenter pilot study. Circ Cadiovasc Imaging. 2008;1:131–40.CrossRef
8.
Zurück zum Zitat Nagarahara D, Nakata T, Hashimoto A, et al. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function. J Nucl Med. 2008;49:225–33.CrossRef Nagarahara D, Nakata T, Hashimoto A, et al. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function. J Nucl Med. 2008;49:225–33.CrossRef
9.
Zurück zum Zitat Flotats A, Carrió I, Agostini D, Le Guludec D, Marcassa C, Schaffers M, et al. Proposal for standadization of 123-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging. 2010;37:1802–12.PubMedCrossRef Flotats A, Carrió I, Agostini D, Le Guludec D, Marcassa C, Schaffers M, et al. Proposal for standadization of 123-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging. 2010;37:1802–12.PubMedCrossRef
10.
Zurück zum Zitat Simões MV, Pintya AO, Bromberg-Marin G, Sarabanda AV, Antloga CM, Pazin-Filho A, et al. Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas’ cardiomyopathy. Am J Cardiol. 2000;86(9):975–81.PubMedCrossRef Simões MV, Pintya AO, Bromberg-Marin G, Sarabanda AV, Antloga CM, Pazin-Filho A, et al. Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas’ cardiomyopathy. Am J Cardiol. 2000;86(9):975–81.PubMedCrossRef
Metadaten
Titel
Test the Heart Nerves: True Grit for Prognosis?
verfasst von
Marcus V. Simões
J. Antonio Marin-Neto
Publikationsdatum
01.08.2011
Verlag
Current Science Inc.
Erschienen in
Current Cardiovascular Imaging Reports / Ausgabe 4/2011
Print ISSN: 1941-9066
Elektronische ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-011-9094-4

Weitere Artikel der Ausgabe 4/2011

Current Cardiovascular Imaging Reports 4/2011 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.